HLS Therapeutics Investor Relations Material

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of prescription medications for the treatment of central nervous system (CNS) and cardiovascular conditions. The company specializes in bringing established medications to market, primarily targeting chronic conditions that require long-term treatment. HLS Therapeutics serves patients and healthcare providers across North America with a portfolio of branded medications. The company is headquartered in Toronto, Canada, and its shares are listed on the TSX.